camptothecin has been researched along with betadex in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (15.56) | 29.6817 |
2010's | 31 (68.89) | 24.3611 |
2020's | 7 (15.56) | 2.80 |
Authors | Studies |
---|---|
Anderson, BD; Xiang, TX | 1 |
Bauer-Brandl, A; Brandl, M; Nguyen, NB; Saetern, AM | 1 |
Cheng, J; Davis, ME; Khin, KT; Schluep, T | 1 |
Bailly, C; Bonte, JP; Dias, N; Foulon, C; Goossens, JF; Lansiaux, A; Mahieu, C; Principe, P; Vaccher, C | 1 |
Apostolakis, J; Kämper, A; Lengauer, T; Steffen, A; Strassnig, C; Thiele, C; Tietze, S; Wenz, G | 1 |
Liu, YY; Tang, MF; Yu, Y; Zhang, GB | 1 |
Anderson, BD; Joguparthi, V | 1 |
Cui, W; Li, X; Luo, X; Xie, C; Yang, Y; Zhou, S; Zou, J | 1 |
Fang, X; Jiang, Y; Sha, X; Zhang, W | 1 |
Allard, E; Benoit, JP; Bilensoy, E; Calış, S; Cırpanlı, Y; Lemaire, L; Passirani, C | 1 |
Karatgi, P; Nekkanti, V; Paruchuri, S; Pillai, R | 1 |
Bilensoy, E; Calis, S; Cirpanli, Y; Dogan, AL | 1 |
Cui, J; Li, C; Li, Y; Wang, C; Wang, P; Wei, N; Xiu, X; Zhang, L | 1 |
Chen, Y; Fang, X; Gu, J; Jiang, X; Jiang, Y; Law, K; Sha, X; Xin, H; Zhang, W | 1 |
Chen, JX; Chen, WH; Li, C; Xiao, W; Zhang, XZ; Zhuo, RX | 1 |
Fongsuk, C; Manaspon, C; Nasongkla, N; Nittayacharn, P; Vejjasilpa, K | 1 |
Li, X; Liu, C; Luo, X; Wang, H; Xie, C; Yan, S | 1 |
Barrera, G; Cavalli, R; Ciamporcero, E; Dianzani, C; Ellis, L; Fantozzi, R; Minelli, R; Pettazzoni, P; Pili, R; Trotta, F | 1 |
Huang, H; Huang, J; Liu, S; Xu, H; Yu, J; Zeng, J | 1 |
Du, F; Huang, J; Liu, S; Lu, W; Luo, P; Luo, Y; Meng, H; Xu, K; Xu, Y; Yu, J | 1 |
Blanchard-Desce, M; Chaix, A; Clément, S; Croissant, J; Durand, JO; Ferris, DP; Gallud, A; Garcia, M; Gary-Bobo, M; Hugues, V; Lu, J; Maynadier, M; Mongin, O; Raehm, L; Tamanoi, F; Tarn, D; Wang, M; Zink, JI | 1 |
Chen, M; Li, X; Luo, X; Wei, J; Zhang, H; Zhang, Y | 1 |
Cao, Y; Chen, JT; Liu, Y; Yang, Y; Zhang, YM | 1 |
Chu, X; Hao, A; Li, S; Liu, G; Ma, M; Shang, W; Xing, P; Zhang, Y | 1 |
Carcaboso, AM; Glisoni, R; Lavarino, C; Monterrubio, C; Mora, J; Paco, S; Rodríguez, E; Schaiquevich, P; Sosnik, A; Vila-Ubach, M | 1 |
Chen, C; Chen, Y; Xiao, Y; Zhang, X | 1 |
Chen, M; Li, X; Luo, X; Wei, J; Xu, G; Zhang, H | 1 |
Barrera, G; Boggio, E; Cappellano, G; Cavalli, R; Conti, L; Dianzani, C; Dianzani, U; Fantozzi, R; Gigliotti, CL; Giovarelli, M; Minelli, R; Occhipinti, S; Pizzimenti, S; Trotta, F | 1 |
Chen, A; Huang, Y; Li, L; Yu, H; Zhang, C; Zhang, G; Zhang, H | 1 |
Jagtiani, T; Liang, JF; Zhan, H | 1 |
Fan, HX; Li, D; Liu, Y; Sun, HL; Yang, Y; Zhang, YM | 1 |
Alarfaj, AA; Amira, F; Arulselvan, P; Arumugam, R; Benelli, G; Danjuma, L; Fakurazi, S; Hamat, RA; Higuchi, A; Krishnan, P; Kumar, SS; Kumari, S; Munusamy, MA; Murugan, K; Pooi Ling, M; Priya, SP; Rajan, M; Sakinah, S | 1 |
Chen, A; Chen, M; Huang, Y; Xu, L; Zhang, G; Zhang, H | 1 |
Enoch, IVMV; Ramasamy, S; Sam David, RJR | 1 |
Chen, X; Gao, C; He, Z; Hua, B; Huang, F; Huang, X; Jacobson, O; Liu, Y; Mao, Z; Wang, W; Wang, Z; Yu, C; Yu, G; Zhang, F; Zhao, X; Zhou, J; Zhu, X | 1 |
Bai, S; Hou, M; Kang, Y; Liu, G; Ma, X; Shi, X; Xu, Z; Xue, P; Zhang, T; Zhang, X | 1 |
Adane, E; Leggas, M; Liu, X; Tang, F | 1 |
Bai, S; Chen, J; Gao, YE; Hou, M; Huang, X; Kang, Y; Ma, X; Shi, X; Wen, F; Xu, Z; Xue, P; Zhang, X | 1 |
Li, T; Liu, Y; Muhammad, N; Wang, J; Zhan, H; Zhao, H | 1 |
Liu, Y; Sheng, X; Wang, J; Zhang, YH; Zhang, YM | 1 |
Aktaş, Y; Benito, JM; Bilensoy, E; Ünal, S | 1 |
Alexander, A; Arivarasu, A; Enoch, IVMV; Kaliyamoorthy, K; Pillai, AS; Ramasamy, S | 1 |
Bai, B; Huang, F; Mao, Z; Qi, S; Yang, K; Yu, G; Yu, X; Zhang, X | 1 |
Chen, H; Ding, N; Guan, Y; Kang, Y; Luo, T; Pang, J; Tong, T; Xing, C; Zhang, S | 1 |
Balan, H; Gupta, R; Pathigoolla, A; Raj, G; Ravi, A; Sureshan, KM; Varghese, R | 1 |
45 other study(ies) available for camptothecin and betadex
Article | Year |
---|---|
Stable supersaturated aqueous solutions of silatecan 7-t-butyldimethylsilyl-10-hydroxycamptothecin via chemical conversion in the presence of a chemically modified beta-cyclodextrin.
Topics: beta-Cyclodextrins; Camptothecin; Cyclodextrins; Drug Stability; Organosilicon Compounds; Pharmaceutical Solutions | 2002 |
Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Camptothecin; Hydrogen-Ion Concentration; Solubility | 2004 |
Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
Topics: Animals; Area Under Curve; beta-Cyclodextrins; Camptothecin; Chromatography, High Pressure Liquid; Colonic Neoplasms; Disease Models, Animal; Female; Half-Life; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Nude; Polymers; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2006 |
Chiral capillary electrophoretic determination of the enantiomeric purity of homocamptothecin derivatives, promising antitumor topoisomerase I inhibitors, using highly sulfated CDs and fluorescence detection.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Buffers; Camptothecin; Electrophoresis, Capillary; Enzyme Inhibitors; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Stereoisomerism; Sulfates; Temperature; Topoisomerase I Inhibitors | 2006 |
Improved cyclodextrin-based receptors for camptothecin by inverse virtual screening.
Topics: beta-Cyclodextrins; Camptothecin; Drug Design; Models, Molecular; Molecular Structure; Solubility | 2007 |
Preparation, characterization, and controlled release of novel nanoparticles based on MMA/beta-CD copolymers.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Camptothecin; Delayed-Action Preparations; Methylmethacrylate; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Spectrophotometry, Infrared; Time Factors | 2007 |
Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Biological Transport; Camptothecin; Chemistry, Pharmaceutical; Excipients; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Liposomes; Organosilicon Compounds; Permeability | 2008 |
Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; Apoptosis; beta-Cyclodextrins; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Stability; Female; Humans; Lactates; Nanofibers; Nanotechnology; Polyethylene Glycols; Surface Properties | 2010 |
Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Area Under Curve; beta-Cyclodextrins; Camptothecin; Drug Evaluation, Preclinical; Drug Stability; Freeze Drying; Half-Life; Hydrogen-Ion Concentration; Hydrolysis; Male; Rats; Rats, Sprague-Dawley; Solubility; Temperature | 2010 |
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Drug Carriers; Drug Compounding; Female; Glioma; Lactic Acid; Nanoparticles; Neoplasm Transplantation; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Inbred F344; Surface-Active Agents | 2011 |
Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Calorimetry, Differential Scanning; Camptothecin; Chemistry, Pharmaceutical; Excipients; Freeze Drying; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Nanoparticles; Particle Size; Powders; Rats; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2011 |
Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Cell Line; Drug Delivery Systems; Humans; Lactic Acid; Mice; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2010 |
Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
Topics: Ammonium Sulfate; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Capsules; Female; Half-Life; Irinotecan; Lipids; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Polyethylene Glycols; Prostatic Neoplasms; Technology, Pharmaceutical | 2011 |
Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred ICR; Sarcoma 180; Toxicity Tests, Chronic; Xenograft Model Antitumor Assays | 2011 |
A plug and play polymeric template driven by supramolecular interactions.
Topics: Animals; beta-Cyclodextrins; Camptothecin; Cell Death; Chlorocebus aethiops; COS Cells; Ethylenediamines; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Naphthaleneacetic Acids; Oligopeptides; Peptides; Polymers; Spectrometry, Fluorescence | 2012 |
SN-38:β-cyclodextrin inclusion complex for in situ solidifying injectable polymer implants.
Topics: Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Drug Implants; Irinotecan; Polymers | 2011 |
Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Carriers; Emulsions; Humans; Lactates; Mice; Neoplasm Transplantation; Neoplasms; Polyethylene Glycols; Tumor Burden | 2012 |
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
Topics: Androgens; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; DNA Damage; Drug Carriers; Histones; Humans; Male; Nanostructures; Particle Size; Phosphorylation; Prostatic Neoplasms; Solubility; Topoisomerase I Inhibitors | 2012 |
Hollow nanosphere fabricated from β-cyclodextrin-grafted α,β-poly(aspartic acid) as the carrier of camptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; beta-Cyclodextrins; Biopolymers; Camptothecin; Cell Survival; Cells, Cultured; Drug Carriers; Drug Compounding; Fibrosarcoma; Mice; Nanospheres; Tumor Cells, Cultured; Water | 2013 |
CPT loaded nanoparticles based on beta-cyclodextrin-grafted poly(ethylene glycol)/poly (L-glutamic acid) diblock copolymer and their inclusion complexes with CPT.
Topics: beta-Cyclodextrins; Camptothecin; Cell Survival; Glutamic Acid; Humans; MCF-7 Cells; Nanoparticles | 2014 |
Two-photon-triggered drug delivery via fluorescent nanovalves.
Topics: Azo Compounds; beta-Cyclodextrins; Camptothecin; Drug Delivery Systems; Fluorescence; Humans; Imaging, Three-Dimensional; MCF-7 Cells; Nanoparticles; Photons; Porosity; Propidium; Silicon Dioxide | 2014 |
Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Camptothecin; Drug Carriers; Drug Liberation; Female; Lactates; Lung Neoplasms; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Stilbenes | 2014 |
A small-sized graphene oxide supramolecular assembly for targeted delivery of camptothecin.
Topics: Adamantane; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Carriers; Graphite; Humans; Hyaluronic Acid; Mice; NIH 3T3 Cells; Oxides | 2014 |
A supramolecular vesicle of camptothecin for its water dispersion and controllable releasing.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Dimethyl Sulfoxide; Drug Liberation; HeLa Cells; Humans; Membranes, Artificial; Water | 2015 |
Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Heterografts; Humans; Hydrophobic and Hydrophilic Interactions; Irinotecan; Mice; Mice, Nude; Microdialysis; Neuroblastoma | 2015 |
Liposomes Encapsulating 10-Hydroxycamptothecin-Cyclodextrin Complexes and Their In Vitro Anti-Tumor Activities.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Hep G2 Cells; Humans; Liposomes | 2015 |
Tunable release of chemotherapeutic and vascular disrupting agents from injectable fiber fragments potentiates combination chemotherapy.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; beta-Cyclodextrins; Bibenzyls; Camptothecin; Cell Line, Tumor; Cell Proliferation; Drug Liberation; Drug Therapy, Combination; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Neoplasms; Tumor Microenvironment | 2016 |
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer.
Topics: Absorption, Physicochemical; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cell Survival; Diffusion; Humans; Male; Mice; Mice, SCID; Nanocapsules; Porosity; Prostatic Neoplasms | 2016 |
Combined use of ionic liquid and sulfobutylether-β-cyclodextrin as electrolyte additives for separation and determination of camptothecin alkaloids by CZE.
Topics: beta-Cyclodextrins; Camptothecin; Electrophoresis, Capillary; Imidazoles; Ionic Liquids; Limit of Detection; Linear Models; Reproducibility of Results | 2016 |
Enhanced anticancer activity of drug nanoparticles formulated with β-cyclodextrin.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Drug Stability; Humans; Lung Neoplasms; Nanoparticles; Solubility | 2017 |
Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.
Topics: Adamantane; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Delayed-Action Preparations; Drug Carriers; Drug Screening Assays, Antitumor; Dynamic Light Scattering; HCT116 Cells; Humans; Hyaluronic Acid; Mice; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Nanoparticles; NIH 3T3 Cells; Solubility | 2016 |
Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; beta-Cyclodextrins; Camptothecin; Colonic Neoplasms; Edetic Acid; Ferric Compounds; G1 Phase; HT29 Cells; Humans; Nanoconjugates | 2017 |
Simultaneous separation and analysis of camptothecin alkaloids in real samples by large-volume sample stacking in capillary electrophoresis.
Topics: beta-Cyclodextrins; Camptotheca; Camptothecin; Electrophoresis, Capillary; Fruit; Hydrogen-Ion Concentration; Linear Models; Plant Bark; Plant Extracts; Reproducibility of Results; Sensitivity and Specificity; Temperature | 2018 |
Folate-molecular encapsulator-tethered biocompatible polymer grafted with magnetic nanoparticles for augmented drug delivery.
Topics: beta-Cyclodextrins; Biocompatible Materials; Camptothecin; Capsules; Dextrans; Drug Carriers; Drug Liberation; Ferric Compounds; Folic Acid; HeLa Cells; Humans; Magnetite Nanoparticles; Models, Molecular; Molecular Conformation; Nickel; Zinc Compounds | 2018 |
Supramolecular Polymer-Based Nanomedicine: High Therapeutic Performance and Negligible Long-Term Immunotoxicity.
Topics: Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Camptothecin; Female; Glutathione; HeLa Cells; Humans; Nanomedicine; Neoplasms; Positron-Emission Tomography; Solubility | 2018 |
Starburst Diblock Polyprodrugs: Reduction-Responsive Unimolecular Micelles with High Drug Loading and Robust Micellar Stability for Programmed Delivery of Anticancer Drugs.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Drug Delivery Systems; Female; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Micelles; Polymers; Prodrugs; Tumor Microenvironment | 2019 |
Pharmacokinetic modeling of the blood-stable camptothecin analog AR-67 in two different formulations.
Topics: Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Excipients; Glycerol; Male; Mice; Mice, Inbred C57BL; Models, Biological; Organosilicon Compounds; Tissue Distribution | 2019 |
Codelivery of doxorubicin and camptothecin by dual-responsive unimolecular micelle-based β-cyclodextrin for enhanced chemotherapy.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; HeLa Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; MCF-7 Cells; Mice; Micelles; Nanoparticles; Oxidation-Reduction; Polyethylene Glycols; Polymethacrylic Acids; Spheroids, Cellular | 2019 |
Lytic peptide-grafted beta-cyclodextrin polymer based nano-scaled drug delivery system with enhanced camptothecin anti-cancer efficacy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; beta-Cyclodextrins; Biological Availability; Camptothecin; Cell Line, Tumor; Cell Movement; Cellulose; Cyclodextrins; Down-Regulation; Drug Delivery Systems; Hep G2 Cells; Humans; MCF-7 Cells; Nanoparticles; Peptides; Signal Transduction; Solubility; Up-Regulation | 2020 |
Enzyme-responsive fluorescent camptothecin prodrug/polysaccharide supramolecular assembly for targeted cellular imaging and in situ controlled drug release.
Topics: Adamantane; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Drug Carriers; Drug Liberation; Fluorescent Dyes; HCT116 Cells; Humans; Hyaluronic Acid; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Naphthalimides; NIH 3T3 Cells; Prodrugs | 2020 |
Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Cell Line; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Mice; Mucus; Nanoparticles | 2020 |
β-Cyclodextrin-folate functionalized poly(lactic-co-glycolide)-superparamagnetic ytterbium ferrite hybrid nanocarrier for targeted delivery of camptothecin.
Topics: beta-Cyclodextrins; Camptothecin; Drug Carriers; Ferric Compounds; Folic Acid; Humans; Magnetic Iron Oxide Nanoparticles; Nanoparticles; Ytterbium | 2021 |
A Hybrid Supramolecular Polymeric Nanomedicine for Cascade-Amplified Synergetic Cancer Therapy.
Topics: beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Humans; Iron; Nanomedicine; Nanoparticles; Neoplasms; Polymers | 2022 |
Cyclodextrin-based supramolecular nanoparticles break the redox balance in chemodynamic therapy-enhanced chemotherapy.
Topics: beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cyclodextrins; Glutathione; Humans; Male; Metallocenes; Methacrylates; Nanoparticles; Oxidation-Reduction; Polyethylene Glycols; Reactive Oxygen Species | 2022 |
Adamantoid Scaffolds for Multiple Cargo Loading and Cellular Delivery as β-Cyclodextrin Inclusion Complexes.
Topics: beta-Cyclodextrins; Calorimetry; Camptothecin; Crystallography, X-Ray; HeLa Cells; Humans | 2023 |